nx_trial_ethics.nx

nx_trial_ethics.nx -- GTM SUITE / ETHICAL TRIAL PARTNER rung. Scores jurisdictions as places to run clinical development on INTEGRITY axes, not only on cost and speed -- because who you develop with is a choice, and the opioid era is what happens when that choice is made badly. WHY THIS FILE EXISTS. Purdue Pharma pleaded guilty to federal felonies in 2007 and again in 2020 for misrepresenting the addiction risk of OxyContin. That was not a regulator being permissive by design -- it was a regulator being CAPTURED and DECEIVED. Which means the defence is structural: pick systems where independent ethics review, mandatory results disclosure and low institutional corruption make that capture harder. This rung makes that comparable instead of rhetorical. THE AXES, AND WHY EACH ONE IS HERE: CPI Transparency International's Corruption Perceptions Index -- published, 0-100, higher is cleaner. The single best available proxy for institutional capture risk. ICH-GCP adherence to the international good-clinical-practice standard: informed consent, monitoring, data integrity. RESULTS DISCLOSURE mandatory posting of results, including NEGATIVE ones. Selective publication is how OxyContin's risk profile stayed obscured; a regime that compels disclosure is structurally harder to game. ETHICS INDEPENDENCE whether review sits with a body independent of the sponsor and the institution. INJURY COMPENSATION whether a harmed participant is compensated without having to litigate. PORTABILITY whether the data is accepted by FDA and EMA. This matters for a reason worth stating plainly: choosing an ethical partner does NOT cost you the US market, because ICH-compliant foreign data is accepted by FDA. You can decline to develop in a system you distrust and still sell there later. ONE HONEST NON-DIFFERENTIATOR. Industry fee funding of regulators is a real conflict -- FDA's human drugs programme is roughly half user-fee funded, and EMA is MORE fee-dependent, not less. Because it is near-universal it does not separate these jurisdictions, so it is documented here rather than scored, to avoid manufacturing a distinction that does not exist.